[Initial observations on the use of levamisole in the immunostimulation treatment of patients operated on for lung cancer].
The results obtained with levamisole in the immunostimulating of 59 resected and non-resected lung carcinoma patients are presented. The effectiveness of the treatment was assessed in terms of survival, length of the free interval, etc. Cutireaction to the drug was repeatedly monitored. It is felt that the overall results were insufficient evidence of the true effectiveness of this manner of treatment, even though some data indicative of the therapeutic action of the drug were obtained.
D004137:Dinitrochlorobenzene / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects*; D007978:Levamisole / Q000627:therapeutic use*; D008175:Lung Neoplasms / Q000601:surgery*; D011379:Prognosis; D012882:Skin Tests
D004137:Dinitrochlorobenzene; D007978:Levamisole
Prime osservazioni sull impiego del Ievamisolo nel trattamento immunostimolante dei pazienti operati di resezione per carcinoma polmonare.